Soft-absorbent adhesive foam dressing containing a protease inhibitor (TLC-NOSF) with a vapour permeable backing and silicone adhesive border. The TLC-NOSF Healing Matrix inhibits matrix metalloproteinases promotes angiogenesis. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.
Moderately to heavily exuding leg ulcers, diabetic foot ulcers, pressure ulcers, and long-standing acute wounds.
Do not use on infected or critically colonised wounds, on cancerous wounds, fistulas, which may reveal a deep abscess, or if there is a known sensitivity to the dressing
8x8cm; 10x10cm; 13x13cm; 15x20cm; 20x20cm (sacrum)
£5.20; £6.17; £8.56; £11.01; £14.79